Ignite Creation Date:
2024-05-06 @ 2:13 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT01991938
Status:
TERMINATED
Last Update Posted:
2017-01-27
First Post:
2013-11-18
Brief Title:
Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
Sponsor:
Verastem Inc
Organization:
Verastem Inc
Organization Data
Organization:
Verastem Inc
Class:
INDUSTRY
Study ID:
VS-5584-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Verastem Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None